Stay updated on CT103A in High-risk Multiple Myeloma: FUMANBA-2 Clinical Trial
Sign up to get notified when there's something new on the CT103A in High-risk Multiple Myeloma: FUMANBA-2 Clinical Trial page.

Latest updates to the CT103A in High-risk Multiple Myeloma: FUMANBA-2 Clinical Trial page
- ChecktodayChange DetectedVersion 3.6.4 was added to the record history, replacing the previous version 3.6.3. This reflects an internal platform update to the page rendering rather than a modification to the study data or content.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe history shows a new revision entry labeled v3.6.3, replacing v3.6.2. This represents a platform or UI update to the record history page rather than changes to the study data.SummaryDifference0.1%

- Check29 days agoChange DetectedThe version history now lists a new site revision, v3.6.2, replacing the previous v3.6.0 entry. This reflects an underlying platform/template update rather than a change to the study record data.SummaryDifference0.1%

- Check43 days agoChange DetectedThe study record history gains two new links: 'Check who can join' and 'Find Contact Information', guiding users to eligibility details and how to contact the study team. A new 'Revision: v3.6.0' tag appears, signaling an updated version of the study record.SummaryDifference0.6%

- Check50 days agoChange DetectedA new revision (v3.5.5) was added to the record history, replacing the previous v3.5.4, indicating an update to the study record.SummaryDifference0.1%

- Check72 days agoChange DetectedA new revision entry (v3.5.4) appears, replacing the previous v3.5.3, indicating a minor release update to the page’s version history rather than changes to study data.SummaryDifference0.1%

Stay in the know with updates to CT103A in High-risk Multiple Myeloma: FUMANBA-2 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CT103A in High-risk Multiple Myeloma: FUMANBA-2 Clinical Trial page.